Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

被引:130
|
作者
Fu, HY
Muenzer, J
Samulski, RJ
Breese, G
Sifford, J
Zeng, XH
McCarty, DM
机构
[1] Univ N Carolina, Gene Therapy Ctr, Sch Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/j.ymthe.2003.08.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The blood-brain barrier is the main obstacle to efficient delivery of therapeutic reagents, including viral vectors, into the central nervous system (CNS) for treating global CNS diseases. In this study, the effects of mannitol infusions on global brain gene expression of a novel AAV vector were examined after intravenous (iv) or intracisternal injection. Initially, a self-complementary adeno-associated virus serotype 2 vector (scAAV) was compared to traditional single-stranded AAV2 vector for reporter gene expression in the brain of adult mice with or without pretreatment of an iv mannitol infusion. One to two months postinjection, analysis of vector-transduced green fluorescent protein (GFP) expression in the brain revealed that vector delivery to the CNS via iv injection required pretreatment with mannitol. This expression was observed only when scAAV vectors were used. Using these conditions, transgene expression was observed in various neurons and glial cells throughout the brain. The peripherally administered scAAV vectors also transduced the cells in multiple somatic tissues with efficient expression in liver (20-30% of hepatocytes), but was less efficient in other somatic tissues. Intracisternal injection of scAAV vector produced a broad and intense transgene expression in both neurons and glial cells in the CNS of injected mice ranging from the olfactory area to the brain stem and spinal cord. More than 50% of the Purkinje cells in the cerebellum expressed GFP. Intravenous infusion of mannitol before intracisternal injection of the scAAV vector enhanced the dispersion of the vector in the CNS. Further optimization of these steps combining peripheral and intracisternal scAAV gene delivery should facilitate the development of treatments for global CNS diseases, especially diseases involving both the somatic system and the CNS, such as lysosomal storage disorders.
引用
收藏
页码:911 / 917
页数:7
相关论文
共 50 条
  • [1] Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain
    Fu, HY
    Muenzer, J
    Samulski, RJ
    Breese, GR
    Sifford, JO
    Zeng, XN
    McCarty, DM
    MOLECULAR THERAPY, 2003, 7 (05) : S15 - S15
  • [2] Improvement of Monoamine Metabolism in Phenylketonuria Mouse Brain Treated with a Self-Complementary Adeno-Associated Virus Vector
    Yagi, Hiroya
    Sanechica, Sho
    Ichinose, Hiroshi
    Mizukami, Hiroaki
    Ogura, Tsuyoshi
    Urabe, Masashi
    Hamada, Hiromi
    Yoshikawa, Hiroyuki
    Ozawa, Keiya
    Kume, Akihiro
    MOLECULAR THERAPY, 2009, 17 : S70 - S70
  • [3] Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain
    Donsante, A.
    McEachin, Z.
    Riley, J.
    Leung, C. H.
    Kanz, L.
    O'Connor, D. M.
    Boulis, N. M.
    GENE THERAPY, 2016, 23 (05) : 401 - 407
  • [4] Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain
    A Donsante
    Z McEachin
    J Riley
    C H Leung
    L Kanz
    D M O'Connor
    N M Boulis
    Gene Therapy, 2016, 23 : 401 - 407
  • [5] Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector
    Yagi, Hiroya
    Ogura, Tsuyoshi
    Mizukami, Hiroaki
    Urabe, Masashi
    Hamada, Hiromi
    Yoshikawa, Hiroyuki
    Ozawa, Keiya
    Kume, Akihiro
    JOURNAL OF GENE MEDICINE, 2011, 13 (02): : 114 - 122
  • [6] Sustained Correction of Hyperphenylalaninemia in Female Pahenu2 Mouse by a Self-Complementary Adeno-Associated Virus Vector
    Kume, Akihiro
    Ogura, Tsuyoshi
    Matsushita, Takashi
    Mizukami, Hiroaki
    Urabe, Masashi
    Okada, Takashi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2006, 13 : S87 - S87
  • [7] Complete normalization of hyperphenylalaninemia in female Pahenu2 mouse by a self-complementary adeno-associated virus vector
    Kume, Akihiro
    Ogura, Tsuyoshi
    Matsushita, Takashi
    Mizukami, Hiroaki
    Urabe, Masashi
    Okada, Takashi
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2006, 8 (12): : 1444 - 1445
  • [8] Genomic stability of self-complementary recombinant adeno-associated virus 2 in mouse muscle
    Ren, CC
    Kumar, S
    Ponnazhagan, S
    MOLECULAR THERAPY, 2004, 9 : S284 - S284
  • [9] Efficient gene expression by self-complementary adeno-associated virus serotype 2 and 5 in various human cancer cells
    Lee, Han Saem
    Shin, Oh Kyo
    Kim, Sung Jin
    Lee, Won Il
    Jeong, Sunjoo
    Park, Keerang
    Choe, Han
    Lee, Heuiran
    ONCOLOGY REPORTS, 2007, 18 (03) : 611 - 616
  • [10] Use of Self-Complementary Adeno-Associated Virus Serotype 2 as a Tracer for Labeling Axons: Implications for Axon Regeneration
    Liu, Yingpeng
    Keefe, Kathy
    Tang, Xiaoqing
    Lin, Shen
    Smith, George M.
    PLOS ONE, 2014, 9 (02):